Last updated: 7 June 2024 at 5:48pm EST

Richard Ono Net Worth




The estimated Net Worth of Richard Dana Ono is at least $55.4 Thousand dollars as of 20 March 2023. Richard Ono owns over 4,000 units of Lipocine Inc stock worth over $55,370 and over the last 11 years he sold LPCN stock worth over $0. In addition, he makes $0 as Director at Lipocine Inc.

Richard Ono LPCN stock SEC Form 4 insiders trading

Richard has made over 4 trades of the Lipocine Inc stock since 2014, according to the Form 4 filled with the SEC. Most recently he bought 4,000 units of LPCN stock worth $1,360 on 20 March 2023.

The largest trade he's ever made was exercising 5,250 units of Lipocine Inc stock on 16 December 2020 worth over $20,580. On average, Richard trades about 882 units every 179 days since 2014. As of 20 March 2023 he still owns at least 14,125 units of Lipocine Inc stock.

You can see the complete history of Richard Ono stock trades at the bottom of the page.





Richard Ono biography

Dr. Richard Dana Ono is Director of the Lipocine Inc. Dr. Ono brings 30 years of experience managing public and private life science companies. Throughout his career, he has been engaged in strategic planning, product management, technology acquisition, and commercial development for multiple early stage life science companies and has been involved in a number of key advances for the industry. Dr. Ono has founded several biotech companies in the U.S., including IntraImmune Therapies, Inc., a biotechnology company which he sold to Abgenix, Inc. (now Amgen), along with several successful early stage biotech companies in the Boston area. Currently, he is a venture partner at VIMAC Ventures LLC. Dr. Ono received his AB in Earth & Planetary Sciences from The Johns Hopkins University and his AM and PhD in Biology from Harvard University, where he also completed a program in business administration.



How old is Richard Ono?

Richard Ono is 62, he's been the Director of Lipocine Inc since 2014. There are 3 older and 9 younger executives at Lipocine Inc. The oldest executive at Lipocine Inc is Dr. Mahesh V. Patel Ph.D., 64, who is the Co-Founder, Interim Principal Financial Officer, Chairman, Pres & CEO.

What's Richard Ono's mailing address?

Richard's mailing address filed with the SEC is C/O 675 ARAPEEN DR, SUITE 202, SALT LAKE CITY, UT, 84108.

Insiders trading at Lipocine Inc

Over the last 11 years, insiders at Lipocine Inc have traded over $9,045 worth of Lipocine Inc stock and bought 890,945 units worth $696,169 . The most active insiders traders include Mahesh V. Patel, John W. Higuchi, and Morgan R Brown. On average, Lipocine Inc executives and independent directors trade stock every 72 days with the average trade being worth of $148,846. The most recent stock trade was executed by Mahesh V. Patel on 25 May 2023, trading 8,706 units of LPCN stock currently worth $43,791.



What does Lipocine Inc do?

lipocine inc., a specialty pharmaceutical company, develops and commercializes pharmaceutical products. the company develops drugs based on hydroance, a drug delivery technology. it primarily focuses on developing oral versions of several hormones for use in men and women health. the company’s lipid-based technology platform offers non-invasive delivery solutions for small polar organics and macromolecules. it also offers custom drugs for pharmaceutical/biotechnology companies. lipocine inc. was founded in 1997 and is headquartered in salt lake city, utah.



What does Lipocine Inc's logo look like?

Lipocine Inc logo

Complete history of Richard Ono stock trades at Lipocine Inc and Inhibitor Therapeutics

Date
#
Company
Insider
Trans.
Transaction
Shares Price per share Total value Shares after Source
20 Mar 2023 Richard Dana Ono
Director
Buy 4,000 $0.34 $1,360
20 Mar 2023
14,125
16 Dec 2020 Richard Dana Ono
Director
Option 5,250 $1.38 $7,245
16 Dec 2020
10,125
29 Dec 2017 Richard Dana Ono
Director
Option 1,750 $3.44 $6,020
29 Dec 2017
5,750
19 Nov 2014 Richard Dana Ono
Director
Buy 4,000 $5.14 $20,560
19 Nov 2014
4,000


Lipocine Inc executives and stock owners

Lipocine Inc executives and other stock owners filed with the SEC include: